A REVIEW OF HEALTH TECHNOLOGY ASSESSMENT GUIDELINES ON THE APPROVAL OF BIOSIMILARS

被引：0
|
作者：
Balijepalli, C. [1 ]
Desai, K. [1 ]
Yan, K. [2 ]
Zoratti, M. [3 ]
Marshall, L. [4 ]
White, N. [5 ]
Franklin, M. [4 ]
Druyts, E. [1 ]
机构：
[1] Pharmalyt Grp, Vancouver, BC, Canada
[2] Univ British Columbia, Vancouver, BC, Canada
[3] Zoratti HEOR Consulting, Oakville, ON, Canada
[4] Franklin Pharmaceut Consulting LLC, Rock Hill, SC USA
[5] Franklin Pharmaceut Consulting LLC, Arlington, VA USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PNS278
引用
收藏
页码：S810 / S810
页数：1
相关论文
共 50 条
  • [31] ETHICS IN HEALTH TECHNOLOGY ASSESSMENT: A SYSTEMATIC REVIEW
    Bellemare, Christian A.
    Dagenais, Pierre
    K.-Bedard, Suzanne
    Beland, Jean-Pierre
    Bernier, Louise
    Daniel, Charles-Etienne
    Gagnon, Hubert
    Legault, Georges-Auguste
    Parent, Monelle
    Patenaude, Johane
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2018, 34 (05) : 447 - 457
  • [32] Ethics in health technology assessment. Review
    Garcia-Leon, F. J.
    JOURNAL OF HEALTHCARE QUALITY RESEARCH, 2019, 34 (01) : 20 - 28
  • [33] Health technology assessment in Canada - A decade in review
    Menon, D
    Topfer, LA
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2000, 16 (03) : 896 - 902
  • [34] Systematic review for new health technology assessment
    Lee, Seon Heui
    Choi, Won-jung
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2012, 55 (03): : 279 - 291
  • [35] Good Practice Guidelines for Decision-Analytic Modelling in Health Technology AssessmentA Review and Consolidation of Quality Assessment
    Zoë Philips
    Laura Bojke
    Mark Sculpher
    Karl Claxton
    Su Golder
    PharmacoEconomics, 2006, 24 : 355 - 371
  • [36] Immunomodulating therapy for patients with multiple sclerosis: Health technology assessment and guidelines
    Twork, S.
    Voigt, K.
    Menning, M.
    Rotter, T.
    Poehlau, D.
    Kugler, J.
    AKTUELLE NEUROLOGIE, 2008, 35 (02) : 70 - 80
  • [37] Differences among formulary submission guidelines: Implications for health technology assessment
    Mauskopf, Josephine
    Walter, Jeffrey
    Birt, Julie
    Bowman, Lee
    Copley-Merriman, Catherine
    Drummond, Michael
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2011, 27 (03) : 261 - 270
  • [38] Approval of biosimilars in the USA-dead ringers?
    不详
    LANCET, 2012, 379 (9817): : 686 - 686
  • [39] Approval Process An overview of biosimilars in the oncology setting
    Sowinski-Raff, Lisa
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2018, 22 (05) : 13 - 18
  • [40] The US Biosimilars ActChallenges Facing Regulatory Approval
    Cecil Nick
    Pharmaceutical Medicine, 2012, 26 (3) : 145 - 152
12345